Hyosung Chemical Corporation (298000.KS)
KRW 48400.0
(-3.97%)
KRW 48400.0
(-3.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2791.62 Billion | 2878.55 Billion | 2452.99 Billion | 1817.18 Billion | 1812.47 Billion | 1116.77 Billion |
| Cost of Revenue | 2869.42 Billion | 3108.71 Billion | 2203.71 Billion | 1664.13 Billion | 1568.88 Billion | 1002.16 Billion |
| Gross Profit | -77.79 Billion | -230.15 Billion | 249.27 Billion | 153.05 Billion | 243.58 Billion | 114.6 Billion |
| Operating Expenses | 106.78 Billion | 106.57 Billion | 100.7 Billion | 92.12 Billion | 89.69 Billion | 49.6 Billion |
| Selling, General and Administrative Expenses | 43.34 Billion | 43.85 Billion | 38.57 Billion | 34.97 Billion | 35.59 Billion | 19.61 Billion |
| Research and Development Expenses | 20.24 Billion | 20.88 Billion | 21.78 Billion | 20.2 Billion | 20.99 Billion | 13.56 Billion |
| Other Expenses | 34.41 Billion | 41.83 Billion | 40.34 Billion | 36.95 Billion | 33.1 Billion | -1.38 Billion |
| Cost and Expenses | 2980.46 Billion | 3215.28 Billion | 2304.41 Billion | 1756.26 Billion | 1658.58 Billion | 1051.77 Billion |
| Operating Income | -188.83 Billion | -336.72 Billion | 148.57 Billion | 60.92 Billion | 153.88 Billion | 64.99 Billion |
| Interest Expense | 47.91 Billion | 101.1 Billion | 34.16 Billion | 43.52 Billion | 36.51 Billion | 21.04 Billion |
| Income Tax Expense | -25.68 Billion | -39.38 Billion | 43.95 Billion | 15.03 Billion | 22.19 Billion | 7.02 Billion |
| Earnings before Tax | -368.52 Billion | -448.25 Billion | 114.37 Billion | 3.42 Billion | 110.01 Billion | 27.41 Billion |
| Net Income | -346.91 Billion | -408.86 Billion | 58.41 Billion | -11.61 Billion | 87.82 Billion | 20.39 Billion |
| Earnings Per Share Basic | -106.72 Thousand | -128.66 Thousand | 18.38 Thousand | -3655.52 | 27.63 Thousand | 6412.35 |
| Earnings Per Share Diluted | -106.08 Thousand | -128.66 Thousand | 18.38 Thousand | -3655.52 | 27.63 Thousand | 6412.00 |
| Weighted Average Shares Outstanding | 3.25 Million | 3.17 Million | 3.17 Million | 3.17 Million | 3.17 Million | 3.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.27 Million | 3.17 Million | 3.17 Million | 3.17 Million | 3.17 Million | 3.18 Million |
| Gross Margin | -0.03 | -0.08 | 0.10 | 0.08 | 0.13 | 0.10 |
| EBIT Margin | 0.02 | -0.02 | 0.14 | 0.13 | 0.16 | 0.12 |
| Profit Margin | -0.12 | -0.14 | 0.02 | -0.01 | 0.05 | 0.02 |
| EBITDA | 49.81 Billion | -60.59 Billion | 328.04 Billion | 237.86 Billion | 311.22 Billion | 138.11 Billion |
| Earnings Before Tax Margin | -0.07 | -0.12 | 0.06 | 0.03 | 0.08 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 768.31 Billion | 754.48 Billion | 710.34 Billion | 2791.62 Billion | 686.53 Billion | 711.72 Billion |
| Cost of Revenue | - | 777.57 Billion | 717.43 Billion | 2873.67 Billion | 695.47 Billion | 688.46 Billion |
| Gross Profit | 768.31 Billion | -23.09 Billion | -7.09 Billion | -82.04 Billion | -8.94 Billion | 23.26 Billion |
| Operating Expenses | 794.48 Billion | 805.2 Billion | 745.17 Billion | 106.78 Billion | 28.52 Billion | -26.09 Billion |
| Selling, General and Administrative Expenses | - | 22.43 Billion | 22.55 Billion | - | 24.07 Billion | 26.09 Billion |
| Research and Development Expenses | - | 5.19 Billion | 5.18 Billion | - | 4.44 Billion | 4.76 Billion |
| Other Expenses | -794.48 Billion | -805.2 Billion | -745.17 Billion | -1.57 Billion | -723.99 Billion | -52.19 Billion |
| Cost and Expenses | 794.48 Billion | 805.2 Billion | 745.17 Billion | 2980.46 Billion | 723.99 Billion | 688.46 Billion |
| Operating Income | -26.17 Billion | -50.71 Billion | -34.82 Billion | -188.83 Billion | -37.46 Billion | -2.83 Billion |
| Interest Expense | - | 44.19 Billion | 43.6 Billion | 173.06 Billion | 42.32 Billion | 43.75 Billion |
| Income Tax Expense | -12.99 Billion | -7.46 Billion | -6.68 Billion | -24.98 Billion | -11.34 Billion | -3.74 Billion |
| Earnings before Tax | -74.19 Billion | -97.52 Billion | -80.58 Billion | -368.52 Billion | -84.78 Billion | -51.78 Billion |
| Net Income | -61.2 Billion | -90.06 Billion | -73.9 Billion | -346.91 Billion | -74.1 Billion | -48.03 Billion |
| Earnings Per Share Basic | -16.14 Thousand | -27.54 Thousand | -22.59 Thousand | - | -20.23 Thousand | -15.11 Thousand |
| Earnings Per Share Diluted | -16.14 Thousand | -27.54 Thousand | -22.59 Thousand | - | -20.23 Thousand | -15.11 Thousand |
| Weighted Average Shares Outstanding | 3.79 Million | 3.27 Million | 3.27 Million | 3.27 Million | 3.66 Million | 3.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.79 Million | 3.27 Million | 3.27 Million | 3.27 Million | 3.66 Million | 3.17 Million |
| Gross Margin | 1.00 | -0.03 | -0.01 | -0.03 | -0.01 | 0.03 |
| EBIT Margin | -0.03 | -0.07 | -0.05 | - | 0.01 | 0.03 |
| Profit Margin | -0.08 | -0.12 | -0.10 | -0.12 | -0.11 | -0.07 |
| EBITDA | -26.17 Billion | -50.71 Billion | -34.82 Billion | - | 6.24 Billion | 23.26 Billion |
| Earnings Before Tax Margin | -0.03 | -0.07 | -0.05 | -0.07 | -0.05 | -0.00 |
NYMTN
0565
0QNH
ARROW
CODX
AC